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Screening for breast cancer: medicalisation, visualisation and the embodied 
experience 
Abstract 
Women’s perspectives on breast screening (mammography and breast awareness) 
were explored in interviews with midlife women sampled for diversity of background 
and health experience. Attending mammography screening was considered a social 
obligation despite women’s fears and experiences of discomfort. Women gave 
considerable legitimacy to mammography visualisations of the breast, and the expert 
interpretation of these. In comparison, women lack confidence in breast awareness 
practices, directly comparing their sensory capabilities with those of the mammogram, 
although mammography screening does not substitute breast awareness in a straight 
forward way. The authors argue that reliance on visualising technology may create a 
fragmented sense of the body, separating the at risk breast from embodied experience.  
 
Keywords: breast screening, medical imaging, embodiment, medicalisation 
mammography, breast awareness 
 
Introduction 
Women’s midlife has become subject to extensive medical intervention and 
monitoring, from treatment of menopausal hormone changes with hormone 
replacement therapy (HRT), to monitoring of bone density and screening for breast 
cancer. Medicalisation, used in its original sociological sense, implies the ever-
expanding jurisdiction of medicine over everyday lives and so-called ‘normal events’ 
such as birth, death and ageing, sexuality, fertility and childhood behaviour (Zola, 1977; 
Illich, 1975) and, as a concept, medicalisation highlights the social, moral and political 
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as well as the scientific dimensions of medical knowledge. Second wave feminist 
writing, in particular, developed the medicalisation critique to reveal the use of 
medicine as an agent of social control and of the social construction of gender and 
sexuality, highlighting how these discourses have historically constituted a site of 
sexual discrimination. However, since the 1990’s a range of debates suggest that the 
medicalisation thesis may be overly simplistic (see for example Roberts, 2002) and that 
women are not passive victims of medical ‘imperialism’, but negotiate the range of 
subject positions available to them (Wadsworth and Green, 2003).  
 
This paper examines how the nature of medical technology influences women’s 
negotiated positions in relation to medicalisation. The technology on which this paper 
focuses is breast screening, by which we mean actions taken by women and health 
professionals to detect changes in the breast which may indicate early breast cancer. 
Breast screening focuses on women as breast cancer is relatively rare in men.  
 
Screening for breast cancer 
Screening for breast cancer includes the following approaches: 
 
- ‘breast awareness’, that is women being aware of the look and feel of their 
breasts, what is normal for them, noting any changes of concern such as lumps 
and reporting them to a doctor (NHS Cancer Screening Programmes, 2006) 
- breast checks by a health professional where a doctor or nurse checks a 
woman’s breasts on a regular basis (e.g. annually) 
- mammography visualization with x-rays  which is then interpreted by an 
expert. 
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The field work for this paper was undertaken in the UK which has a publicly funded 
mammography screening programme inviting all women aged 50-70 years for 
mammography every three years (Advisory committee on Breast Cancer Screening, 
2006). This population screening programme is run independently of responsive 
health care, such as general practice, with the letters of invitation and results going 
direct to women. A similar system is found in a number of other countries e.g. 
Denmark, Canada and Australia (Jørgensen and Gøtzsche, 2006). In the UK, the 
programme was established in 1987 following a national report demonstrating that 
early detection and treatment would reduce the rate of early death from breast cancer 
(Forrest, 1986). Three quarters of women invited for mammography screening take up 
the invitation (Cancer Research UK, 2004; Advisory committee on Breast Cancer 
Screening, 2006) and the national screening programme estimates that the programme 
saves 1400 lives each year in England. This means ‘for every 400 women screened 
regularly over a 10 year period, one woman fewer will die from beast cancer than 
would have died without screening’ (Advisory committee on Breast Cancer 
Screening, 2006: 1). 
 
However, the value of mammography screening has been questioned (Dixon, 2006). 
A review of benefits and harms found that while screening reduced breast cancer 
mortality, it also led to over diagnosis and over treatment (Gøtzsche and Nielson, 
2006). In promoting attendance at mammography screening, invitations and 
accompanying information tend to exaggerate the benefit of the programme and down 
play potential harms (Thornton et al., 2003; Jørgensen and Gøtzsche, 2006; Slaytor 
and Ward, 1998). In summary, the balance of risks and benefits is still disputed, with 
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particular concern about the extent to which women are appropriately informed about 
both (Webster and Austoker, 2006). 
 
Breast awareness is also promoted, having replaced self-examination in the early 
1990s after doubts were raised about the efficacy of the more formal self-examination 
(Austoker, 2003; NHS Cancer Screening Programmes, 2006). A review of two large 
trials found that breast self-examination did not reduce mortality but did increase the 
number of biopsies performed (Kösters and Gøtzsche, 2003). The numbers of women 
who follow advice on breast awareness or self-examination is unknown (Pfeffer, 
2004b) but studies have found that most women do not examine their breasts 
regularly (Kearney, 2006; Babrow and Kline, 2000). The effectiveness of breast 
awareness for reducing mortality has not yet been adequately evaluated (Pfeffer, 
2004a) but other benefits have been suggested, including empowerment of women in 
regard to their health (McCready et al., 2005).  
 
There is a lack of evidence for any benefit from regular breast checks by doctors and 
nurses (Vainio and Bianchini, 2002) and in the UK such checks are not encouraged. 
Therefore this study does not consider this type of breast screening. 
 
Medicalisation and women’s agency in breast cancer screening  
Over-simplistic assumptions that medicine has only been a source of women’s 
oppression have been tempered by claims that it has also contributes to their liberation. 
Over the course of history, women have sought out and engaged actively with the 
medicalisation of childbirth to reduce mortality, infection and pain (Reissman, 1983) and 
in contemporary times continue to seek technological interventions to improve their lives 
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(Williams and Calnan, 1996; Griffiths, 1999a; Roberts, 2002). Cancer is one of the 
health problems most feared by midlife women (Griffiths, 1995) and many women 
have personal, embodied experience of breast cancer or know of someone who has 
experienced breast cancer. This is borne out in the prevalence rates: one in nine 
women in the UK will develop it at some point in their lives (Office of National 
Statistics, 2005). In addition, breast cancer has a high public profile – it is four times 
more likely to be headline news than any other cancer (Saywell cited in Gibbon, 
2007: 2). Women actively participate in screening and even demand services. In the 
1970s, the women’s health movement largely advocated self-help in place of 
institutionalized medicine that was seen as paternalistic and disempowering, but by 
the 1980s some women’s groups were advocating mammography and campaigning 
for more services (Fitzpatrick, 2006). The 1990s saw the growth of preventative 
health campaigns around the disease in the UK, alongside a culture of disease-specific 
activism, promoting mammography and breast awareness (Gibbon, 2007). However, 
criticism continues from some women’s groups, particularly in relation to the high 
level of corporate involvement in breast awareness campaigns and the lack of 
attention to environmental factors in causing breast cancer (Ehrenreich, 2001; Potts, 
2004). It can also be argued that liberal models of choice in relation to medical 
decision making are flawed due to a lack of attention to the workings of power, the 
inherent uncertainties in medical knowledge, and the almost impossible complexity of 
factors relating to health (Roberts, 2007: 146). Evidence about the causes of most 
breast cancer is insufficient to calculate an individual’s risk.  
 
In considering whether they themselves are candidates for breast cancer, women 
compare themselves with idealized others, including those with higher ‘risk’, by 
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‘strategically amplifying or submerging differences and similarities’ to distance or 
align themselves with breast cancer candidacy (Pfeffer, 2003). The medical response 
to the very real experience of breast cancer for women has been to focus on individual 
responsibility, including attendance at screening (Griffiths et al., 2006). This response 
is reflected in the media coverage of breast cancer with little attention being given to 
other causes beyond individual control (Brown et al., 2001).  Even the most women-
orientated advocacy literature places much emphasis on the evidence that women who 
attend screening have a greater chance of surviving breast cancer diagnosis (Europa 
Donna 2009). 
 
The sociological literature around women’s attitudes to breast screening has often 
focused on reasons for non-compliance, with the goal of improving women’s 
adherence to advice about mammography screening and breast awareness (Kearney, 
2006; Babrow and Kline, 2000). While we know how many women attend for 
mammography, little is known about why women accept or reject the invitation 
(Pfeffer, 2004b). As Howson (1999) has noted in relation to cervical screening, the 
social science literature has tended to present compliance with screening as ‘morally 
neutral’, in other words the desirable, rational, and unproblematic response to health 
information. The brief overview above already points to a more complex situation. 
Indeed, there is strong evidence in the literature that screening programmes imply a 
social obligation to participate – especially for women as they are often represented as 
bearing responsibility for their own health and that of their families (Lupton, 1995; 
Howson, 1999; Bush, 2000). This may be connected with a wider trend reported by 
Rose who argues that, in the twenty-first century, health has become an ethical value 
and the maximization of health a moral obligation. Such principles are ‘inevitably 
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translated into microtechniques for the management of communication and 
information that are inescapably normative and directional. These blur the boundaries 
of coercion and consent’ (Rose, 2007: 29). 
 
As we have outlined, a number of issues add to the complexity of the interplay 
between medicalisation and women’s agency. This study explores this further through 
women’s accounts of breast screening, comparing accounts of mammography 
screening, a medical technology that visualizes the internal substance of the breast, 
and breast awareness undertaken by women themselves, noting their embodied 
feeling of their own breast, from within their breast and through palpating their breast. 
As the impact of the technological visualization of the breast was a theme that 
emerged strongly from women’s accounts, we briefly introduce the issue here before 
describing our study. 
 
Medical visualization and the embodied experience 
Medical images of various kinds are often given more credence than patients’ 
experience (Gunderman, 2005; Henwood, 2001), risking creating a fragmented sense 
of the body. For example Reventlow et al., suggest that bone scans create a distance 
between women and their bodies, as the body becomes an object to be observed by 
experts (Leder cited in Reventlow et al., 2006: 2727). By focusing a ‘technology 
assisted’ medical gaze on specific diseased or at risk body parts, the body itself may 
be represented as fragmented (Green et al., forthcoming). Although many people 
actively engage with screening technologies it is possible that as medicine focuses 
more and more on the bodily interior, and on pre-symptomatic illnesses that are 
generally beyond lay perception, our sense of autonomy and efficacy in relation to our 
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own health may decline (Gunderman, 2005). However, this line of argument is not 
restricted to recent advances in imaging as a similar fragmenting effect has been 
attributed to the ‘low-tech’ medical gaze. Writing about gynaecology, Kapsalis (1997) 
argues that legitimately subjecting female genitals to the medical gaze entails 
elaborate protocols that result in a disembodied vagina, marking it a proper medical 
object rather than pornographic spectacle. The impact of medical visualization of the 
breast on women’s embodied experience of their breast is explored further as we 
consider our interview data. 
 
The study 
In this paper, we use data from interviews undertaken as part of an Economic and 
Social Research Council (ESRC) funded study into the use of health technologies in 
women’s midlife. In order to understand the social impact of health technologies, and 
the specific social processes and mechanisms involved, the study examined the 
approaches used by individual women to health technologies, including breast 
screening, hormone replacement therapy (HRT) and screening for osteoporosis using 
bone densitometry (Green et al., forthcoming; Green et al., 2006; Green et al., 2002; 
Griffiths and Green, 2003; Griffiths et al., 2006; Griffiths et al., 2005). This paper 
focuses on the women’s interview accounts of breast awareness and mammography 
screening. 
 
This paper reports on 61 interviews undertaken with women sampled from across the 
age range 45-64 years.
i
 Of the 61 interviews, 36 were with women purposively 
sampled from community groups and by snowball sampling for diversity of ethnicity, 
sexual orientation and able-bodiedness. The dimensions of diversity were chosen as 
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there was some evidence in the literature that they correlated with level of uptake of 
breast screening (Pfeffer, 2003; Fish and Wilkinson, 2003; Swain et al., 1993). Of the 
36 respondents in the community sample, 7 were British Asian, 12 were lesbian (2 
interviews each involved 2 lesbian women), and 7 had a mobility disability. The 
remaining 27 interviewees were recruited from primary health care sites (general 
practice and community women’s health clinics). As there is evidence from the USA 
of reduced uptake of mammography with worsening health (Lane 2000), purposive 
sampling was used to ensure diversity on the dimension of living with chronic disease 
(9 interviews were with women living with diabetes) and included women who had 
used none of the health interventions (6 women). To ensure diversity of socio-
economic status and context, recruitment was undertaken in two localities in England 
of contrasting affluence. Women from more deprived areas in the UK are less likely 
to take up mammography breast screening (Banks et al., 2002). 
 
Of the women included in the study who were eligible for routine mammography 
screening (aged over 50) 85% had taken up the offer at some time. This is a slightly 
higher uptake rate of mammography screening than that reported in the literature for 
the UK (Cancer Research UK, 2004; Advisory committee on Breast Cancer 
Screening, 2006). The higher uptake rate is at least partly because this study captured 
whether the women had ever participated in mammography screening whereas the 
published figures are based on response to each invitation issued. The higher rate may 
also indicate that women with more interest in the focal health interventions 
participated in the study. This tendency was addressed to some extent by specifically 
sampling women who had not used the health interventions at all. 
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Lupton (1999) suggests that health maintaining practices are incorporated into the 
life-world of individuals, rather than being stand alone, informed choices, so the 
interviews began by asking respondents to give an account of their lives in general. 
The respondents were encouraged to describe their health and health experiences 
before focusing on their stories in relation to the health interventions. These stories 
tended to locate the health interventions within broader personal and cohort 
experiences. This was followed up by probing questions informed by earlier research 
(Green and Wadsworth, 1998a; Griffiths, 1999b; Watson et al., 1996; Milburn, 1996). 
Respondents were asked about the way they had approached any decisions about the 
health interventions including the influence of their social situation and feelings of 
vulnerability. Where the respondent had not already talked about how they understood 
the health interventions, this was explored. The interviews were audio recorded, 
transcribed and coded in NVivo for ease of data retrieval. A translator was used for 
four interviews. 
 
Initial analysis involved the team each reading selected interview transcripts then 
identifying concepts for further analysis guided by the theoretical positions outlined in 
the introduction. Key concepts included the negotiation of medicalisation through the 
lived body, how women move between different accounts of their body, the limits 
technology imposes on women’s agency in the negotiation and the concept of a 
visualised body (Howson, 2001; Green et al., 2006). Analysis proceeded by constant 
comparison of all transcripts (Green and Thorogood, 2004), looking for similarity and 
differences between each respondent’s transcript and those already analysed. 
Throughout analysis quality assurance processes were used, including: checking of 
transcripts against the audio-recording and independent identification of concepts for 
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analysis by more than one researcher before comparing, discussing and refining them. 
Once final coding was agreed the whole data set was re-analysed to search for 
previously unidentified themes and possible contradictions. During analysis we 
looked for patterns of responses that related to the background or previous 
experiences of our participants, however no clear patterns were found. Instead, a 
complex variation in responses within each of the sample groups was identified. 
 
The results of analysis are presented here in three sections. First, the theme of 
mammography screening as a social obligation is explored. This is not an unexpected 
finding, as it mirrors the findings of previous research in relation to cervical 
screening. It is briefly explored here in relation to screening mammography because 
social obligation is an important contextual factor to women’s experiences of 
medicalized embodiment and technological visualization. The subsequent section 
examines mammography screening and the visualized breast, and the final section of 
the results considers breast awareness and the lived body. The analysis draws out the 
differences and potential tensions between the technical visualization and self-
awareness of the lived body in relation to women’s perceptions and experiences. The 
themes are illustrated with quotations from the interviews. Where women expressed 
views that were radically different from or contrary to our main findings we describe 
these minority views and provide illustrative quotations. 
 
Mammography screening as social obligation 
Sociological research has found that participation in cervical screening is motivated at 
least in part by notions of self-responsibility and social obligation rather than a 
rational choice based upon an understanding of risk (Howson, 1999; Bush, 2000). The 
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women in our study expressed similar views, presenting mammography screening as 
something automatically taken up when offered, a routine social obligation accepted 
without question: 
 
I just think, something that you’ve got to have done. They send the letter 
through the door, up to you to just go.  I don’t necessarily think about it. 
(Woman 96) 
 
I’ve had breast screening and cervical smear tests. I always go for them. 
I’ve had two or three, I think, of the, the breast…and it hurt and…But I think 
I’d probably always go for my smear tests and my breast screening. (Woman 
26) 
 
A sense of obligation was not only expressed in relation to women’s own behaviour.  
A few interviewees in this study generalized their comments to other women, 
communicating a sense that the obligation to attend screening was incumbent on all 
women: 
 
Oh I think it’s essential.  Pity more people don’t umm sort of take it up.  I 
think a lot of people are frightened about going (Woman 73) 
 
Rose argues that prudence in regard to health has become obligatory and those who 
do not adopt an active approach to future health, especially women, risk negative 
judgements (2007: 25). Bush (2000) found that attendance for cervical smear tests 
was perceived by women as the ‘normal’ and ‘correct’ form of behaviour and the 
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women in her study also applied this to both their own behaviour and that of other 
women. Many women in our study mentioned fear and discomfort associated with 
going for screening but nonetheless most of these women attended. Howson (1999) 
found that overcoming the discomfort and embarrassment of cervical screening was 
perceived as an integral part of behaving responsibly and demonstrated age related 
maturity. This might be more relevant to a screening procedure that commences when 
women are in their 20s, whereas mammography is only offered from age 50 years. 
However, in our interviews women indicate that personal anxiety or discomfort is not 
a good enough reason not to attend for mammography screening, reflecting a sense 
that the ‘civilised’ response to the threat of illness is greater rationality and bodily 
control (Lupton, 1995: 9). 
 
Compliance despite discomfort might also be attributed to fear of breast cancer. It was 
apparent from the interviews that concern about getting breast cancer was 
omnipresent for most women. Many of the women interviewed knew someone who 
had breast cancer. However, not all women accepted the invitation to mammography. 
Reasons for not undergoing mammography included not wanting to be ‘interfered 
with’ (Woman 47), ‘fear of the unknown’ (Woman 44), and not wanting to find 
anything else wrong with you (Woman 02). For one woman the discomfort of having 
a mammogram was connected with a concern about damage to the breast. She 
claimed:  
 
...risk of breast cancer increases the more mammograms you have, 
because of the trauma to breast tissue (Woman 46)  
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Webster and Austoker similarly found that a minority of women expressed concerns 
about potential damage caused by the pressure exerted during a mammogram 
(Webster and Austoker, 2006). Up to 35% of women report pain with mammography 
and this is a recognized deterrent to screening (Miller et al., 2008). Nonetheless, 
woman 46 is unusual in considering the potential risks of mammography in her 
decision-making.  
 
Women described mammography screening as a routine obligation that they fulfilled 
and then forgot about for three years. These findings, although not unexpected, 
illustrate some of the complexities around the medicalisation thesis including the 
balancing of risk and benefit and of reassurance and anxiety, and the acceptance by 
many women of a medicalized, externalized concept of the body in need of expert 
monitoring. The way mammography screening impacts on women’s sense of 
responsibility for their own bodies, particularly its visual nature and its timing is 
explored further in the next section.  
 
Mammography screening and the visualized breast 
For most women in our study mammography screening offered reassurance by 
providing a ‘window’ into the body (Brown and Webster, 2004; Haraway, 1991), and 
by telling them something about their breasts that they could not know through their 
own embodied experience: 
 
I feel happy having a mammogram, seeing some kind of in depth look at you, 
to see if you’re alright. (Woman 16 who had breast cancer in the past) 
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 This experience of being outside of their bodies and looking in was also expressed by 
women in this study in relation to bone densitometry (Green et al., 2006). 
Mammography is a visual prosthesis – a technology with which to look inside the 
body in order to detect threats that women themselves cannot see or feel: 
 
I think they’re very good, because I know somebody that didn’t think there 
was anything wrong with them, they didn’t know anything, and they found 
they’d got early signs of breast cancer. (Woman 15) 
 
You become very aware... that cancer can come into your life so easily, so 
rapidly, that you like to think that there’s all these things there to help you... 
the facilities are there to help you…monitor the change in your body. (Woman 
08) 
 
The interviews suggest that women compare their own sensory capabilities, their own 
breast awareness, with mammography technology and find them lacking: 
 
I suppose you take it for granted really. I’m glad that it was there for me to 
have it done. I mean sometimes I check my breasts and you’ve got that many 
little gristly bits and lump…you don’t know really whether something’s there 
or not. You know, so I thought well once you have the mammography you 
think ‘well, they’ve checked it now, that’s that done,’ you know, so you know 
there’s nothing there. (Woman 30) 
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Woman 30 talks in terms of ‘something’ (presumably cancer), as foreign, or a threat 
to her body. The mammogram is the technology that finds this ‘something’ and so by 
association is looking for things that are alien to, rather than part of, her lived body. 
Although she checks her own breasts, her account suggests that she is more reassured 
by the mammogram results than by breast awareness techniques. Another woman 
talks about having more frequent mammograms, by paying for them, in order to be 
confident that nothing is changing in her breasts. These accounts remind us that 
medical visualizations of various kinds become associated with scientific objectivity 
in a way that other forms of knowing about the body are not (Reventlow et al., 2006; 
Sandelowski, 2000; Sandelowski, 1994). The elevated position of mammography 
seems to link, at least in part, with the idea that vision is the most highly valued 
within a hierarchy of senses (Urry, 2000). Woman 30’s bodily experiences do not 
give her the same confidence or feelings of safety that she associates with the 
visualization of the breast and the interpretation of these images by experts. Most 
women in our study gave mammography considerable legitimacy, appearing to rely 
upon the technology to understand the ‘health’ of their breasts, and privileging it over 
breast awareness: 
 
machines that are cleverer than you are looking at you every three years which 
is a reassurance really. (Woman 04) 
 
I mean, it’s three years, isn’t it, or something like that so I suppose things can 
change in that time but I always feel because you’ve had a continual flow of 
negative results you do feel, that’s it, that’s forgotten for a while now and then 
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when the next one is due you just have it done. It does make you feel safe 
definitely. (Woman 17) 
 
Most women in our study talked about mammography screening as something that 
they accepted but which was peripheral to their life:  
 
Yes I’ve always been and it doesn’t worry me. At a certain age, you get a 
letter from the doctor to attend that sort of thing. I don’t really read about it all. 
It doesn’t monopolise my life at all.  (Woman 18) 
 
Once I had it done and got my letter to say ‘oh, you, you’re clear. It’s okay.’ 
And I just carried on with my life. (Woman 30) 
 
Although it may seem desirable that women who receive the ‘all clear’ can quickly 
forget about the test, the impact of the screening may be more complex. Reading the 
women’s accounts, there is a strong sense that they value the reassurance obtained 
from screening mammography but, through the technological imaging process, their 
breasts become ‘virtual breasts’, outside of their control and themselves and in need 
of technology to monitor them. As Brown and Webster (2004) point out, medical 
technologies can empower and simultaneously confuse and they suggest that a 
defining feature of new medical technologies is the tension between opening up and 
closing down of options and subjectivities.  Most of the women felt some degree of 
reassurance from mammography screening and it could be argued that, in the context 
of a high incidence of breast cancer, this reassurance is empowering to some degree. 
However, it is also clear from the women’s accounts, and from other data from the 
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wider project, that there is simultaneous confusion since some women are falsely 
reassured by mammography screening; feeling they are ‘OK’, that is to say risk free, 
for the three years after it has taken place (Griffiths et al., 2005; Griffiths et al., 2006). 
It is almost as though the visualized breasts, the ones dealt with by mammography, 
are ‘parked’ for three years. They are not part of the woman’s lived body and so 
remain unchanged, outside of their daily experience. This runs counter to the breast 
awareness message and encourages women to become less aware of their own breasts 
between screenings, with potentially negative implications for early detection of 
cancers by the women themselves. Pfeffer has noted that ‘BA [breast awareness] 
demands a 24/7 state of vigilance whereas, in sending out invitations every three 
years, the NHSBSP [National Health Service Breast Screening Programme] suggests 
that a different time frame is important. Women found these conflicting messages 
about the significance of time confusing’ and therefore may assume that screening 
mammography and breast awareness are ‘interchangeable’ (Pfeffer, 2004a: 228). 
However, at present, only half of all breast cancers found in women in the age group 
invited for mammography screening are diagnosed at screening. The other half, occur 
in women who do not attend screening or who find the cancer in the time between 
screenings (Advisory committee on Breast Cancer Screening, 2006). 
 
The women interviewed overwhelmingly expressed trust in both the technology of 
mammography screening reinforcing their reliance on this visualization for 
reassurance about their breasts. Although a few women mentioned concern about the 
accuracy of the results, most attributed this to human error in reading the results thus 
allowing them to reaffirm faith in the technology itself: 
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You just go and hope you get the all clear and apart from that you just trust 
they’re doing it correctly. There have been a few scares with the readings of 
those. (Woman18) 
 
Women had to trust the experts to interpret the results of the mammography for them. 
The result remains ‘out there’, communicated through an expert, and contained within 
the medical arena: it is not something that she can bring into her lived experience. The 
breast is medicalised, observed and followed up by doctors. It is an unknown to the 
woman and there is no ongoing link between the embodied and the visualized breast.  
In the next section we explore women’s accounts of breast awareness and the lived 
body and how this relates to mammography screening. 
 
Breast awareness and the lived body:  
On the whole, women’s accounts of breast screening focused heavily on the 
technological intervention of mammography screening. Although these accounts were 
woven together with narratives about their embodied experience of breast awareness, 
generally, the women in our study reported more confidence in mammography 
screening than in checking their own breasts.  
 
I always wonder whether I would be doing it properly enough. The confidence 
and the fact that I hadn’t been checking properly and had missed something 
and totally ignored it, I don’t know. (Woman 17) 
 
A similar lack of confidence about knowing what kind of changes to look for has also 
been found in other studies of self-examination and breast awareness (Fish and 
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Wilkinson, 2003; Pfeffer, 2004a). In our study, most women felt mammography was 
more efficient than breast awareness. For example, this woman has engaged with 
breast awareness but indicates greater reliance on mammography screening: 
 
I’ve just gone along for the screening; I’ve seen the leaflets (about breast 
awareness). I’ve actually done (it) in the past, felt for any lumps, etcetera. I 
know it can pick up most if you have the screen (mammography) you can pick 
up most tumours fairly quickly. (Woman 02) 
 
One woman explained how she hadn’t found a breast lump herself until after 
mammography screening had found it: 
 
I’d actually done mine (breast awareness) but hadn’t found the lump, but when 
I had the mammogram, and they sent for me to go back, I had another poke 
around and found it myself. (Woman16) 
 
The benefits of mammography screening lie in being able to visualise small changes 
in the breast that cannot be detected by touch. The practice of breast awareness asks 
women to be alert to changes that can be felt.  However, the quotations above imply 
that women directly compare their own sensory abilities with those of the 
mammogram, and suggest that their embodied sense of breast changes is perceived as 
unreliable. In contrast, other research has shown that breast awareness can be 
perceived as empowering, giving women a sense that they can play a role in 
countering cancer by remaining vigilant (McCready et al., 2005). In our study a few 
women were clear about their own role in countering cancer, describing how they had 
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come to develop this. Rather than responding to a broad social obligation, one woman 
drew on the experience of her mother’s cancer to explain her vigilance, which 
includes both mammography screening and breast awareness in seemingly equal 
measure: 
My mum died of cancer…she was told she was dying - she came and told us 
and she made us all promise whatever happened that we would check our 
breasts and we have always done it and that and when it was time we had to 
go and get our breasts screened, which we did... (Woman 95). 
 
Health professionals, in particular those not involved in mammography screening, 
sometimes had a role in returning a woman’s ‘at risk’ breast to embodied experience 
by promoting breast awareness. For example this woman was encouraged by her GP 
to check her breasts herself: 
 
it’s (mammography screening) always been normal, so I haven’t ever had 
anything to worry about there, but I do even so check because…the doctor 
explained it very carefully to me when I went on to this cream, HRT cream. 
She said you know there was just a very slight risk of problems with breasts 
with this cream so just keep checking even though you do use a mammogram 
service. (Woman 19) 
 
For most of the women in our study visual technology of mammography screening 
was considered superior to the felt awareness of changes in the breast, reducing 
women’s confidence in their own role in vigilance for cancer except where women 
had specific reason or support for claiming this role. This lack of confidence seemed 
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to find expression in how those women who engaged with breast self awareness 
described it – as something casual – ‘I don’t do anything sort of serious or regular’ 
(Woman 04) – or done in passing – ‘I’ve done it (breast awareness) to a small extent 
really… (in the) shower or bath, you do it quickly.’ (Woman18). A few women 
resisted practicing breast awareness either because they did not consider themselves at 
risk – ‘it won’t happen to me syndrome’ (Woman 17) – or because they felt sure they 
would notice if something was different without consciously checking: 
 
I don’t.  I suppose wickedly I assume that I’ll notice if there’s any lumps. I 
don’t know whether I would but I always assume I’ll notice without me prying 
around to see (Woman 03) 
 
However, as for many women in our study, woman 03 expresses a sense of behaving 
incorrectly by not taking breast awareness seriously. Even the women who minimize 
the importance of breast awareness feel some sense of obligation to monitor their own 
body. 
 
Conclusions 
Prevention of breast cancer in the UK has focused heavily on early diagnosis, 
including screening mammography. From our data, it is clear that, at present, women 
see mammography screening as key to tackling breast cancer, and afford it great 
legitimacy. They submit to screening as a routine social obligation and garner 
reassurance about their health from the procedure. Our study suggests that many 
women perceive their at risk breasts as something external to the self to be submitted 
to technological surveillance. Mammography screening remains peripheral to daily 
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life, something to be endured every three years and forgotten about quickly. The 
medicalised ‘at risk’ breast requiring expert technological surveillance is ‘parked’ by 
women for the three years between routine mammography screenings and bears little 
relation to the women’s embodied experience. The submission to screening, seen by 
the majority of women as inevitable, seems to result in a sense of loss of women’s 
agency. 
 
The nature of the mammography as a visualisation of the body’s interior enhances its 
legitimacy. Women understandably described the technology as providing a ‘window 
into the body’ and as a source of information otherwise not available to them. Breast 
awareness techniques based on what can be felt with the sense of touch or through 
bodily awareness, were directly compared by women with the visualizing technology 
and found lacking, undermining women’s confidence in their role of monitoring their 
own breasts. Although a sense of social obligation was also present in women’s 
accounts of breast self-awareness, only a few women spoke confidently about their 
role in self-monitoring. It is possible that this was in part due to embarrassment in 
talking about breast awareness practices compared to the attendance at mammography 
screening, but many women had already talked in the interviews about their bodily 
experience of the menopause, which included observations about similar embodied 
changes.  
 
Our findings suggest for breast screening there is a complex interplay of 
medicalisation and women’s agency, modulated by the nature of the medical 
screening technology and the imperative women feel (or do not feel) for their own 
role in self-monitoring for breast cancer. This, in turn, has implications for health care 
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policy and practice. An over-reliance by women on experts making decisions about 
their visualized breast could delay diagnosis, whereas self awareness and confidence 
in their own agency to detect changes could be beneficial for early detection and 
treatment. Understanding the uneasy tension between the externalized, medicalised 
and visualized breast and the ‘embodied’ breast which is still very much part of 
women’s corporeal identity is important, not only for women themselves, but also for 
those in the health professions and health promotion services aiming to encourage 
early detection of breast cancer. 
REFERENCES 
Advisory Committee on Breast Cancer Screening (2006) Screening for breast cancer 
in England: past and future. Sheffield, NHS Screening Programmes.  
Austoker, J. (2003) Breast Self Examination. British Medical Journal, 326, 1-2. 
Babrow, A. S. & Kline, K. N. (2000) From "reducing" to "coping with" uncertainty: 
reconceptualizing the central challenge in breast self-exams. Social Science 
and Medicine, 51, 1805-1816. 
Banks, E., Beral, V., Cameron, R., Hogg, A., Langley, N., Barnes, I., Bull, D., 
Reeves, G., English, R., Taylor, S., Elliman, J. & Harris, C. (2002) 
Comparison of various characteristics of women who do and do not attend for 
breast cancer screening. Breast Cancer Research, 4, R1. 
Brown, N. & Webster, A. (2004) New Medical Technologies and Society: reordering 
life, Cambridge, Polity. 
Brown, P., Zavestoski, S., Mccormick, S., Mandelbaum, J. & Luebke, T. (2001) Print 
media coverage of environmental causation of breast cancer. Sociology of 
Health and Illness, 23, 747-775. 
Bush, J. (2000) "It's just part of being a woman": Cervical Screening, the Body and 
Femininity. Social Science and Medicine, 50, 429-444. 
Cancer Research UK (2004) Breast Cancer and Breast Screening CancerStats Report. 
London, Cancer Research UK. 
Dixon, J. M. (2006) Screening for breast cancer. British Medical Journal, 332, 499-
500. 
Economic and Social Data Service (n.d.) ESDS Qualidata website [Online] Available 
from: http://www.esds.ac.uk/qualidata/ (accessed 01 Dec 2008) 
Ehrenreich, B. (2001) Welcome to Cancerland: A mammogram leads to a cult of pink 
kitsch. Harper's Magazine, November, 43-53. 
Europa Donna (2009) The European Breast Cancer Coalition Guide to Breast Health, 
Milan, The European Breast Cancer Coalition. 
Fish, J. & Wilkinson, S. (2003) Understanding Lesbian's Healthcare Behaviour: The 
Case of Breast Self-Examination. Social Science & Medicine, 56, 235-245. 
Fitzpatrick, M. (2006) The Men's Health Movement: A Morbid Symptom. Journal of 
Men's Health and Gender, 3, 258-262. 
 160609 
   25  
Forrest, A. P. M. (1986) Breast Cancer Screening: Report to the Health Minister of 
England, Wales, Scotland and Northern Island. London, HMSO. 
Gibbon, S. (2007) Breast Cancer Genes and the Gendering of Knowledge: Science 
and Citizenship in the Cultural Context of the 'New' Genetics, Basingstoke, 
Palgrave Macmillan. 
Gøtzsche, P. C. & Nielson, M. (2006) Screening for Breast Cancer with 
Mammography. Cochrane Databse of Systematic Reviews, 4. 
Green, E., Griffiths, F. & Lindenmeyer, A. (forthcoming) ‘It can see into your bones’: 
Gender, ICTs and decision making about midlife women’s health. In Balka, 
E., Green, E. & Henwood, F. (Eds.) Informing Gender? Health and 
Information Technologies in Context. Basingstoke, Palgrave Macmillan. 
Green, E., Griffiths, F. & Thompson, D. (2006) 'Are My Bones Normal Doctor?' The 
Role of Technology in Understanding and Communicating Health Risks for 
Midlife Women. Sociological Research Online, 11, not paginated. 
Green, E., Thompson, D. & Griffiths, F. E. (2002) Narratives of Risk: women at 
midlife, medical 'experts' and health technologies. Health Risk and Society, 4, 
243-86. 
Green, E. & Wadsworth, G. (1998a) Disintegrating bodies: an analysis of women's 
experiences of the menopausal body. Making Sense of the Body: Theory 
Research and Practice. British Sociological Association. 
Green, J. & Thorogood, N. (2004) Qualitative Methods for Health Research, London, 
Sage Publications Ltd. 
Griffiths, F. (1999a) Women's control and choice regarding HRT. Social Science & 
Medicine, 42, 469-481. 
Griffiths, F. & Green, E. (2003) A normal biological process? Brittle bones, HRT and 
the patient-doctor encounter. IN Williams, S., Birke, L. & Bendelow, G. (Eds.) 
Debating Biology : Sociological Reflections on Health, Medicine, and Society. 
London, Routledge. 
Griffiths, F., Green, E. & Bendelow, G. (2006) Health professionals, their medical 
interventions and uncertainty: a study focusing on women at midlife. Soc. Sci. 
Med., 62, 1078-1090. 
Griffiths, F., Green, E. & Tsouroufli, M. (2005) The nature of medical evidence and 
its inherent uncertainty for the clinical consultation: qualitative study. British 
Medical Journal, 330, 7490. 
Griffiths, F. E. (1995) Women's Health Concerns: Is the promotion of hormone 
replacement therapy for prevention important to women? Family Practice, 12, 
54-59. 
Griffiths, F. E. (1999b) Women's control and choice regarding HRT. Social Science & 
Medicine, 49, 469-481. 
Griffiths, F. E., Green, E. E., Bendelow, G. & Backett-Milburn, K. (2003) Innovative 
Health Technologies at Women's Midlife; Theory and Diversity among 
women and Experts (L218252038). ESRC. 
Gunderman, R. B. (2005) The Medical Community's Changing Vision of the Patient: 
The Importance of Radiology. Radiology, 234, 339-342. 
Haraway, D. J. (1991) Simians, Cyborgs and Women: The Reinvention of Nature., 
London, Free Association Books. 
Henwood, F. (2001) In/different Screening: Contesting Medical Knowledge in an 
Antenatal Setting. IN Henwood, F., Kennedy, H. & Miller, N. (Eds.) Cyborg 
Lives? Women's Technobiographies. York, Raw Nerve. 
 160609 
   26  
Howson, A. (1999) Cervical Screening, Compliance and Moral Obligation. Sociology 
of Health and Illness, 21, 401-425. 
Howson, A. (2001) "Watching You - Watching Me": Visualising Techniques and the 
Cervix. Women Studies International Forum, 24, 97-110. 
Illich, I. (1975) Medical Nemesis, London, Calder and Boyars. 
Jørgensen, K. & Gøtzsche, P. (2006) Content of invitations for publicly funded 
screening mammography. British Medical Journal, 332, 538-541. 
Kapsalis, T. (1997) Public Privates: Performing Gynecology from Both Ends of the 
Speculum, Durham & London, Duke University Press. 
Kearney, A. J. (2006) Increasing Our Understanding of Breast Self-Examination: 
Women Talk About Cancer, the Health Care System, and Being Women. 
Qualitative Health Research, 16, 802-820. 
Kösters, J. P. & Gøtzsche, P. C. (2003) Regular self-examination or clinical 
examination for early detection of breast cancer. Cochrane Databse of 
Systematic Reviews, 2. 
Lane, D. S., Zapka, J., Breen, N., Messina, C. R. & Fotheringham, D. J. (2000) A 
Systems Model of Clinical Preventive Care: The Case of Breast Cancer 
Screening Among Older Women. . Preventive Medicine, 31, 481-491. 
Lupton, D. (1995) the Imperative of Health: Public Health and the Regulated Body, 
London, Sage Publications Ltd. 
Lupton, D. (1999) Risk, London, Routledge. 
Mccready, T., Littlewood, D. & Jenkinson, J. (2005) Breast Self-Examination and 
Breast Awareness: A Literature Review. Journal of Clinical Nursing, 14, 570-
578. 
Milburn, K. (1996) The importance of lay theorising for health research and practice. 
Health Promotion International, 11, 41-46. 
Miller, D., Livingston, V. & Herbison, P. (2008) Interventions for Relieving Pain and 
Discomfort of Screening Mammography. Cochrane Databse of Systematic 
Reviews, Reviews 2008. 
NHS Cancer Screening Programmes (2006) Breast Awareness [Online] National 
Cancer Screening Programmes. Available from: (accessed 9th March) 
Office of National Statistics (2005) Breast Cancer: Incidence rises while deaths 
continue to fall [Online] Office of National Statistics. Available from: 
www.statistics.gov.uk (accessed 9th March) 
Pfeffer, N. (2004a) "If you think you've got a lump, they'll screen you.": Informed 
Consent, Health Promotion, and Breast Cancer. Journal of Medical Ethics, 30, 
227-230. 
Pfeffer, N. (2004b) Screening for Breast Cancer: Candidacy and Compliance. Social 
Science and Medicine, 58, 151-160. 
Potts, L. K. (2004) An Epidemiology of Women's Lives: The Environmental Risk of 
Breast Cancer. Critical Public Health, 14, 133-147. 
Reissman, C. K. (1983) Women and Medicalization: A New Perspective. Social 
Policy, 14, 3-18. 
Reventlow, S. D., Hvas, L. & Matlterud, K. (2006) Making the Invisible Body 
Visible: Bone Scans, Osteoporosis and Women's Bodily Experiences. Social 
Science & Medicine, 62, 2720-2731. 
Roberts, C. (2002) 'Successful Aging' with Hormone Replacement Therapy: It May 
Be Sexist, But What If It Works? Science as Culture, 11, 39-59. 
Roberts, C. (2007) Messengers of Sex: Hormones, Biomedicine and Feminism, 
Cambridge, Cambridge University Press. 
 160609 
   27  
Rose, N. (2007) The Politics of Life Itself: Biomedicine, Power and Subjectivity in the 
Twenty-First Century, Princeton, Princeton University Press. 
Sandelowski, M. (1994) Separate, but Less Unequal: Fetal Ultrasonography and the 
Transformation of Expectant Mother/Fatherhood. Gender and Society, 8, 230-
245. 
Sandelowski, M. (2000) 'This Most Dangerous Instrument': Propriety, Power, and the 
Vaginal Speculum. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 
29, 74-82. 
Slaytor, E. & Ward, J. (1998) How risks of breast cancer and benefits of screening are 
communicated to women: analysis of 58 pamphlets. British Medical Journal, 
317, 263-4. 
Swain, J., Finkelstein, V., French, S. & Oliver, M. (Eds.) (1993) Disabling Barriers-
Enabling Environments, London, Sage. 
Thornton, H., Edwards, A. & Baum, M. (2003) Women need better information about 
routine mammography. British Medical Journal, 327, 101-103. 
Urry, J. (2000) Sociology Beyond Societies: Mobilities for the Twenty-first Century, 
London, Routledge. 
Vainio, H. & Bianchini, F. (2002) IARC handbooks of cancer prevention. Vol 7: 
breast cancer screening, Lyon, France, IARC Press. 
Wadsworth, G. & Green, E. (2003) Changing women: an analysis of difference and 
diversity in women's accounts of their experiences of menopause. IN Earle, S. 
& Letherby, G. (Eds.) gender, identity and reproduction, social perspectives 
London, Palgrave. 
Watson, J., Cunningham Burley, S., Warson, N. & Milburn, K. (1996) Lay theorizing 
about "the body" and implications for health promotion. Health Education 
Research, 11, 161-172. 
Webster, P. & Austoker, J. (2006) Women's knowledge about breast cancer risk and 
their views of the purpose and implications of breast screening - a 
questionnaire survey. Journal of Public Health, 28, 197-202. 
Williams, S. J. & Calnan, M. (1996) The 'limits' of medicalisation?: modern medicine 
and the lay populace in 'late' modernity. Social Science & Medicine, 42, 1609-
1620. 
Zola, I. (1977) Medicine as an Institution of Social Control. Sociological Review, 20, 
487-98. 
 
 
 
 
 
 
 
                                                 
i
 The larger research project involved an additional 35 interviews with women aged 
45-64 years, interviews with 58 health professionals and 109 recordings of health care 
consultations (Griffiths et al., 2003). Of the interviews with women not included in 
the analysis in this paper, 10 were pilot interviews, 2 women were found to be under 
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45 years of age due to misunderstanding at initial recruitment through a translator and 
19 were with women recruited from secondary care (HRT clinics, bone clinics and 
breast assessment clinics). The latter were not included for this paper as they had a 
very different experience of engaging with the health technologies from the rest of the 
sample of women. A further four interviews were with women who did not agree to 
their interviews being archived ((Economic and Social Data Service, n.d.)) These 
were read by the research team and found to contain no new themes and so, as their 
interviews are not available for wider scrutiny, they are not included here. Where we 
have quoted from women’s interviews, we have labeled the quotations in the same 
way as the archived interviews. In the interviews reported here, some women 
mentioned their past experiences of diagnostic mammography i.e. when 
mammography was undertaken to check the nature of a palpable breast lump. 
Diagnostic use of mammography is not the focus of this paper. 
 
